Patient-Reported Outcomes Measurement Information System Tools for Collecting Patient-Reported Outcomes in Children

Timothy G Brandon1, Brandon D Becker1, Katherine B Bevans2

  • 1Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Insights

Pediatric Patient-Reported Outcomes Measurement Information System (PROMIS) instruments show varying precision and validity in juvenile idiopathic arthritis (JIA) patients. Both patient and parent reports are crucial for a complete health assessment in JIA.

Area of Science:

  • Pediatric Rheumatology
  • Health Outcomes Research
  • Psychometrics

Background:

  • Juvenile idiopathic arthritis (JIA) significantly impacts children's quality of life.
  • Accurate health outcome measurement is essential for effective JIA management.
  • Patient-reported outcomes (PROs) provide valuable insights into a child's experience with JIA.

Purpose of the Study:

  • To assess the precision and construct validity of Patient-Reported Outcomes Measurement Information System (PROMIS) instruments in pediatric JIA patients.
  • To compare the performance of PROMIS short forms and computerized adaptive tests (CATs).
  • To evaluate patient-parent concordance in reporting health outcomes for JIA.

Main Methods:

  • A convenience sample of 228 JIA patients and 223 parents completed PROMIS instruments across 8 domains.
  • Scores were derived from item banks, translated to standardized T scores.
  • Construct validity was assessed by comparing scores between inactive and active disease groups; precision was evaluated using standard errors; patient-parent agreement was measured using intraclass correlations (ICCs).

Main Results:

  • PROMIS instruments demonstrated varying precision and validity depending on the health domain and report type (patient vs. parent).
  • Patient and parent reports significantly differed for anger, fatigue, mobility, and pain interference between disease activity levels.
  • Patient-parent agreement varied (ICC 0.3-0.8), highlighting the need for both perspectives. Short forms and CATs showed comparable reliability.
  • Computerized adaptive tests (CATs) did not reduce item count compared to short forms.

Conclusions:

  • The precision and discriminatory ability of PROMIS instruments in pediatric JIA are domain- and report-type dependent.
  • Varying patient-parent concordance underscores the importance of incorporating both self- and proxy-reports for comprehensive JIA health assessments.
  • PROMIS instruments are valuable tools, but their interpretation requires consideration of patient-specific factors and reporting perspectives.
Abstract

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Pulse Assessment Sites01:11

Pulse Assessment Sites

Pulse assessment sites are crucial in evaluating a patient's cardiovascular health. By assessing the pulsations of arteries at specific anatomical locations, healthcare professionals can gather valuable information about blood flow, heart rate, and peripheral circulation. Understanding these pulse assessment sites is essential for conducting comprehensive cardiovascular evaluations and monitoring patients' overall health. These sites are strategically chosen due to the accessibility and...
3.2K